Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

Lancet. 2003 Mar 1;361(9359):777-80. doi: 10.1016/s0140-6736(03)12663-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Apolipoproteins B / blood*
  • Cholesterol / blood*
  • Cholesterol, LDL / blood
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / drug therapy*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Risk Factors

Substances

  • Anticholesteremic Agents
  • Apolipoproteins B
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol